SharePost Content Read More Yahoo Finance #finance Post navigation Genmab A/S (GMAB) Shares Gain Analyst Support as Deutsche Bank Sees Oncology Upside Exelixis, Inc. (EXEL) Sees Mixed Analyst Actions as Zanzalintinib Nears Commercial Launch